345 related articles for article (PubMed ID: 28759727)
1. The beneficial effects of resveratrol on steatosis and mitochondrial oxidative stress in HepG2 cells.
Izdebska M; Piątkowska-Chmiel I; Korolczuk A; Herbet M; Gawrońska-Grzywacz M; Gieroba R; Sysa M; Czajkowska-Bania K; Cygal M; Korga A; Dudka J
Can J Physiol Pharmacol; 2017 Dec; 95(12):1442-1453. PubMed ID: 28759727
[TBL] [Abstract][Full Text] [Related]
2. Resveratrol Limits Lipogenesis and Enhance Mitochondrial Activity in HepG2 Cells.
Izdebska M; Herbet M; Gawrońska-Grzywacz M; Piątkowska-Chmiel I; Korga A; Sysa M; Iwan M; Natorska-Chomicka D; Poleszak E; Wróbel A; Mandziuk S; Dudka J
J Pharm Pharm Sci; 2018; 21(1):504-515. PubMed ID: 30522586
[TBL] [Abstract][Full Text] [Related]
3. In vitro treatment of HepG2 cells with saturated fatty acids reproduces mitochondrial dysfunction found in nonalcoholic steatohepatitis.
García-Ruiz I; Solís-Muñoz P; Fernández-Moreira D; Muñoz-Yagüe T; Solís-Herruzo JA
Dis Model Mech; 2015 Feb; 8(2):183-91. PubMed ID: 25540128
[TBL] [Abstract][Full Text] [Related]
4. Resveratrol protects against nonalcoholic fatty liver disease by improving lipid metabolism and redox homeostasis via the PPARα pathway.
Huang Y; Lang H; Chen K; Zhang Y; Gao Y; Ran L; Yi L; Mi M; Zhang Q
Appl Physiol Nutr Metab; 2020 Mar; 45(3):227-239. PubMed ID: 31173696
[TBL] [Abstract][Full Text] [Related]
5. Oleic acid protects saturated fatty acid mediated lipotoxicity in hepatocytes and rat of non-alcoholic steatohepatitis.
Chen X; Li L; Liu X; Luo R; Liao G; Li L; Liu J; Cheng J; Lu Y; Chen Y
Life Sci; 2018 Jun; 203():291-304. PubMed ID: 29709653
[TBL] [Abstract][Full Text] [Related]
6. (+)-Lipoic acid reduces mitochondrial unfolded protein response and attenuates oxidative stress and aging in an in vitro model of non-alcoholic fatty liver disease.
Longhitano L; Distefano A; Musso N; Bonacci P; Orlando L; Giallongo S; Tibullo D; Denaro S; Lazzarino G; Ferrigno J; Nicolosi A; Alanazi AM; Salomone F; Tropea E; Barbagallo IA; Bramanti V; Li Volti G; Lazzarino G; Torella D; Amorini AM
J Transl Med; 2024 Jan; 22(1):82. PubMed ID: 38245790
[TBL] [Abstract][Full Text] [Related]
7. Cellular glutathione in fatty liver in vitro models.
Garcia MC; Amankwa-Sakyi M; Flynn TJ
Toxicol In Vitro; 2011 Oct; 25(7):1501-6. PubMed ID: 21620948
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of NAMPT aggravates high fat diet-induced hepatic steatosis in mice through regulating Sirt1/AMPKα/SREBP1 signaling pathway.
Wang LF; Wang XN; Huang CC; Hu L; Xiao YF; Guan XH; Qian YS; Deng KY; Xin HB
Lipids Health Dis; 2017 Apr; 16(1):82. PubMed ID: 28449683
[TBL] [Abstract][Full Text] [Related]
9. Taurine attenuates the development of hepatic steatosis through the inhibition of oxidative stress in a model of nonalcoholic fatty liver disease in vivo and in vitro.
Murakami S; Ono A; Kawasaki A; Takenaga T; Ito T
Amino Acids; 2018 Sep; 50(9):1279-1288. PubMed ID: 29946793
[TBL] [Abstract][Full Text] [Related]
10. Dietary Polyphenols Protect Against Oleic Acid-Induced Steatosis in an in Vitro Model of NAFLD by Modulating Lipid Metabolism and Improving Mitochondrial Function.
Rafiei H; Omidian K; Bandy B
Nutrients; 2019 Mar; 11(3):. PubMed ID: 30832407
[TBL] [Abstract][Full Text] [Related]
11. Resveratrol Maintains Lipid Metabolism Homeostasis via One of the Mechanisms Associated with the Key Circadian Regulator Bmal1.
Li J; Wei L; Zhao C; Li J; Liu Z; Zhang M; Wang Y
Molecules; 2019 Aug; 24(16):. PubMed ID: 31408938
[TBL] [Abstract][Full Text] [Related]
12. Carbon monoxide releasing molecule-A1 improves nonalcoholic steatohepatitis via Nrf2 activation mediated improvement in oxidative stress and mitochondrial function.
Upadhyay KK; Jadeja RN; Vyas HS; Pandya B; Joshi A; Vohra A; Thounaojam MC; Martin PM; Bartoli M; Devkar RV
Redox Biol; 2020 Jan; 28():101314. PubMed ID: 31514051
[TBL] [Abstract][Full Text] [Related]
13. [Effect of metformin on mitochondrial pathway of apoptosis and oxidative stress in cell model of nonalcoholic fatty liver disease].
Wu PB; Song Q; Yu YJ; Yu HG; Luo HS; Tan SY
Zhonghua Gan Zang Bing Za Zhi; 2020 Jan; 28(1):64-68. PubMed ID: 32023702
[No Abstract] [Full Text] [Related]
14. Oleic acid improves hepatic lipotoxicity injury by alleviating autophagy dysfunction.
Liu X; Li X; Su S; Yuan Y; Liu W; Zhu M; Zheng Q; Zeng X; Fu F; Lu Y; Chen Y
Exp Cell Res; 2023 Aug; 429(2):113655. PubMed ID: 37253404
[TBL] [Abstract][Full Text] [Related]
15. (+)-Lipoic Acid Reduces Lipotoxicity and Regulates Mitochondrial Homeostasis and Energy Balance in an In Vitro Model of Liver Steatosis.
Longhitano L; Distefano A; Amorini AM; Orlando L; Giallongo S; Tibullo D; Lazzarino G; Nicolosi A; Alanazi AM; Saoca C; Macaione V; Aguennouz M; Salomone F; Tropea E; Barbagallo IA; Volti GL; Lazzarino G
Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37833939
[TBL] [Abstract][Full Text] [Related]
16. Peroxisome proliferator-activated receptor-delta agonist ameliorated inflammasome activation in nonalcoholic fatty liver disease.
Lee HJ; Yeon JE; Ko EJ; Yoon EL; Suh SJ; Kang K; Kim HR; Kang SH; Yoo YJ; Je J; Lee BJ; Kim JH; Seo YS; Yim HJ; Byun KS
World J Gastroenterol; 2015 Dec; 21(45):12787-99. PubMed ID: 26668503
[TBL] [Abstract][Full Text] [Related]
17. A human hepatocellular in vitro model to investigate steatosis.
Gómez-Lechón MJ; Donato MT; Martínez-Romero A; Jiménez N; Castell JV; O'Connor JE
Chem Biol Interact; 2007 Jan; 165(2):106-16. PubMed ID: 17188672
[TBL] [Abstract][Full Text] [Related]
18. ASPP2 attenuates triglycerides to protect against hepatocyte injury by reducing autophagy in a cell and mouse model of non-alcoholic fatty liver disease.
Xie F; Jia L; Lin M; Shi Y; Yin J; Liu Y; Chen D; Meng Q
J Cell Mol Med; 2015 Jan; 19(1):155-64. PubMed ID: 25256142
[TBL] [Abstract][Full Text] [Related]
19. Effects of daphnetin on lipid metabolism, insulin resistance and oxidative stress in OA‑treated HepG2 cells.
Liu Y; Liao L; Chen Y; Han F
Mol Med Rep; 2019 Jun; 19(6):4673-4684. PubMed ID: 30957185
[TBL] [Abstract][Full Text] [Related]
20. Alpha-naphthoflavone attenuates non-alcoholic fatty liver disease in oleic acid-treated HepG2 hepatocytes and in high fat diet-fed mice.
Xia H; Zhu X; Zhang X; Jiang H; Li B; Wang Z; Li D; Jin Y
Biomed Pharmacother; 2019 Oct; 118():109287. PubMed ID: 31401392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
